Cancer Research Cancer Research Funding Available Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 59, 4242-4246, September 1, 1999]
© 1999 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neznanov, N.
Right arrow Articles by Oshima, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neznanov, N.
Right arrow Articles by Oshima, R. G.
[Cancer Research 59, 4242-4246, September 1, 1999]
© 1999 American Association for Cancer Research

Advances in Brief

A Single Targeted Ets2 Allele Restricts Development of Mammary Tumors in Transgenic Mice1

Nickolay Neznanov2, Albert K. Man, Hideyuki Yamamoto, Craig A. Hauser, Robert D. Cardiff and Robert G. Oshima2,,3

The Burnham Institute, La Jolla, California 92037 [N. N., A. K. M., H. Y., C. A. H., R. G. O.]; and Department of Pathology, School of Medicine University of California at Davis, Davis, California 95616 [R. D. C.]

Heterozygous female mice carrying a targeted mutation of the Ets2 transcription factor gene were mated with a mouse strain that develops mammary tumors due to the expression of the polyoma virus middle T oncogene. Tumors from females with only one wild-type Ets2 gene were approximately one-half the size of tumors from controls. The smaller size of the tumors was correlated with a more differentiated state of early hyperplastic growths and not to differential growth of the frank tumors or to decreased middle T gene expression. Ets2 may regulate the progression of these aggressive mammary tumors.




This article has been cited by other articles:


Home page
 Microbiol. Mol. Biol. Rev.Home page
M. M. Fluck and B. S. Schaffhausen
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen
Microbiol. Mol. Biol. Rev., September 1, 2009; 73(3): 542 - 563.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Xu, J. Dwyer, H. Li, W. Duan, and J.-P. Liu
Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc
J. Biol. Chem., August 29, 2008; 283(35): 23567 - 23580.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. N. Gunawardane, D. C. Sgroi, C. N. Wrobel, E. Koh, G. Q. Daley, and J. S. Brugge
Novel Role for PDEF in Epithelial Cell Migration and Invasion
Cancer Res., December 15, 2005; 65(24): 11572 - 11580.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S.-Q. Kuang, L. Liao, S. Wang, D. Medina, B. W. O'Malley, and J. Xu
Mice Lacking the Amplified in Breast Cancer 1/Steroid Receptor Coactivator-3 Are Resistant to Chemical Carcinogen-Induced Mammary Tumorigenesis
Cancer Res., September 1, 2005; 65(17): 7993 - 8002.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. Myers, A. D.K. Hill, G. Kelly, E. W. McDermott, N. J. O'Higgins, Y. Buggy, and L. S. Young
Associations and Interactions between Ets-1 and Ets-2 and Coregulatory Proteins, SRC-1, AIB1, and NCoR in Breast Cancer
Clin. Cancer Res., March 15, 2005; 11(6): 2111 - 2122.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. E. Peace, K. Toney-Earley, M. H. Collins, and S. E. Waltz
Ron Receptor Signaling Augments Mammary Tumor Formation and Metastasis in a Murine Model of Breast Cancer
Cancer Res., February 15, 2005; 65(4): 1285 - 1293.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Zhang, S.-Q. Kuang, L. Liao, S. Zhou, and J. Xu
Haploid Inactivation of the Amplified-in-Breast Cancer 3 Coactivator Reduces the Inhibitory Effect of Peroxisome Proliferator-Activated Receptor {gamma} and Retinoid X Receptor on Cell Proliferation and Accelerates Polyoma Middle-T Antigen-Induced Mammary Tumorigenesis in Mice
Cancer Res., October 1, 2004; 64(19): 7169 - 7177.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
G. M. Carbone, S. Napoli, A. Valentini, F. Cavalli, D. K. Watson, and C. V. Catapano
Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells
Nucleic Acids Res., August 16, 2004; 32(14): 4358 - 4367.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. D. Prescott, K. S. N. Koto, M. Singh, and A. Gutierrez-Hartmann
The ETS Transcription Factor ESE-1 Transforms MCF-12A Human Mammary Epithelial Cells via a Novel Cytoplasmic Mechanism
Mol. Cell. Biol., June 15, 2004; 24(12): 5548 - 5564.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. K. Galang, W. J. Muller, G. Foos, R. G. Oshima, and C. A. Hauser
Changes in the Expression of Many Ets Family Transcription Factors and of Potential Target Genes in Normal Mammary Tissue and Tumors
J. Biol. Chem., March 19, 2004; 279(12): 11281 - 11292.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
A. K. Man, L. J. T. Young, J. A. Tynan, J. Lesperance, M. Egeblad, Z. Werb, C. A. Hauser, W. J. Muller, R. D. Cardiff, and R. G. Oshima
Ets2-Dependent Stromal Regulation of Mouse Mammary Tumors
Mol. Cell. Biol., December 1, 2003; 23(23): 8614 - 8625.
[Abstract] [Full Text] [PDF]

Home page
 Plant Physiol.Home page
S. Perelman, M. A. Mazzella, J. Muschietti, T. Zhu, and J. J. Casal
Finding Unexpected Patterns in Microarray Data
Plant Physiology, December 1, 2003; 133(4): 1717 - 1725.
[Abstract] [Full Text]

Home page
 Nucleic Acids ResHome page
G. M. Carbone, E. M. McGuffie, A. Collier, and C. V. Catapano
Selective inhibition of transcription of the Ets2 gene in prostate cancer cells by a triplex-forming oligonucleotide
Nucleic Acids Res., February 1, 2003; 31(3): 833 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Seki, M. A. Suico, A. Uto, A. Hisatsune, T. Shuto, Y. Isohama, and H. Kai
The ETS Transcription Factor MEF Is a Candidate Tumor Suppressor Gene on the X Chromosome
Cancer Res., November 15, 2002; 62(22): 6579 - 6586.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
J. E. Maglione, D. Moghanaki, L. J. T. Young, C. K. Manner, L. G. Ellies, S. O. Joseph, B. Nicholson, R. D. Cardiff, and C. L. MacLeod
Transgenic Polyoma Middle-T Mice Model Premalignant Mammary Disease
Cancer Res., November 1, 2001; 61(22): 8298 - 8305.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. E. Kupferman, M. E. Fini, W. J. Muller, R. Weber, Y. Cheng, and R. J. Muschel
Matrix Metalloproteinase 9 Promoter Activity Is Induced Coincident with Invasion during Tumor Progression
Am. J. Pathol., December 1, 2000; 157(6): 1777 - 1783.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.